Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity
Open Access
- 15 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 12 (2), 1-16
- https://doi.org/10.1038/s41419-021-03458-5
Abstract
Chemotherapy drug-induced nephrotoxicity limits clinical applications for treating cancers. Pyroptosis, a newly discovered programmed cell death, was recently reported to be associated with kidney diseases. However, the role of pyroptosis in chemotherapeutic drug-induced nephrotoxicity has not been fully clarified. Herein, we demonstrate that the chemotherapeutic drug cisplatin or doxorubicin, induces the cleavage of gasdermin E (GSDME) in cultured human renal tubular epithelial cells, in a time- and concentration-dependent manner. Morphologically, cisplatin- or doxorubicin-treated renal tubular epithelial cells exhibit large bubbles emerging from the cell membrane. Furthermore, activation of caspase 3, not caspase 9, is associated with GSDME cleavage in cisplatin- or doxorubicin-treated renal tubular epithelial cells. Meanwhile, silencing GSDME alleviates cisplatin- or doxorubicin-induced HK-2 cell pyroptosis by increasing cell viability and decreasing LDH release. In addition, treatment with Ac-DMLD-CMK, a polypeptide targeting mouse caspase 3-Gsdme signaling, inhibits caspase 3 and Gsdme activation, alleviates the deterioration of kidney function, attenuates renal tubular epithelial cell injury, and reduces inflammatory cytokine secretion in vivo. Specifically, GSDME cleavage depends on ERK and JNK signaling. NAC, a reactive oxygen species (ROS) inhibitor, reduces GSDME cleavage through JNK signaling in human renal tubular epithelial cells. Thus, we speculate that renal tubular epithelial cell pyroptosis induced by chemotherapy drugs is mediated by ROS-JNK-caspase 3-GSDME signaling, implying that therapies targeting GSDME may prove efficacious in overcoming chemotherapeutic drug-induced nephrotoxicity.Keywords
Funding Information
- National Natural Science Foundation of China (81400716)
- Natural Science Foundation of Zhejiang Province (LY20H050007)
- Department of Health of Zhejiang Province (2020383770)
This publication has 53 references indexed in Scilit:
- Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicityJournal of Biomedical Science, 2019
- Cyclin G1 and TASCC regulate kidney epithelial cell G 2 -M arrest and fibrotic maladaptive repairScience Translational Medicine, 2019
- Tenascin-C protects against acute kidney injury by recruiting Wnt ligandsKidney International, 2019
- The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injuryKidney International, 2018
- Néphrotoxicité médicamenteuseNephrologie & Therapeutique, 2018
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapyDrug Resistance Updates, 2016
- Pathophysiology of Cisplatin-Induced Acute Kidney InjuryBioMed Research International, 2014
- Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibDrug Resistance Updates, 2009
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosisAmerican Journal of Physiology-Renal Physiology, 2000